Amplified Sciences is a life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases.
Amplified Sciences is a molecular diagnostics company unlike other diagnostics companies due to their ultra-sensitive molecular sensing technology with composition of matter IP exclusively licensed from Purdue University. The technology is disease state agnostic, can detect to the single molecule level, scales easily to point of care, and provides a very favorable cost structure for their platform of reagents. The first application – early detection of pancreatic cancer - is an assay that will quickly prove the investment thesis due to large unmet medical need and a favorable reimbursement path. The team has delivered a working prototype and published proof of concept data.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 24, 2020 | Seed | $1M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Indiana University Philanthropic Venture Fund | — | Seed |